Insider trading

Period: 12 months Stock: BDX + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

21 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

21 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

21 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

21 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
21 decisions over 12 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
21 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

21 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
28 Sep 2026
Feld Michael EVP, Chief Revenue Officer
Sold on a plan
$13.96K 76 at 183.70
0.4%
Planned (10b5-1)
26 Aug 2026
Feld Michael EVP, Chief Revenue Officer
Sold on a plan
$31.10K 165 at 188.49
0.8%
Planned (10b5-1)
13 Aug 2026
Polen Thomas E Jr Chairman, CEO and President
Sold on a plan
$768.12K 4,152 at 185.00
3.6%
Planned (10b5-1)
11 Aug 2026
Goette Roland EVP and President, EMEA
Sold at will
$440.89K 2,438 at 180.84
14.1%
Not planned
27 Jul 2026
Feld Michael EVP, Chief Revenue Officer
Sold on a plan
$11.78K 75 at 157.13
0.4%
Planned (10b5-1)
26 Jun 2026
Feld Michael EVP, Chief Revenue Officer
Sold on a plan
$11.46K 75 at 152.80
0.4%
Planned (10b5-1)
24 Jun 2026
Garrison Michael David EVP & Pres Med.Essntl&BioPharm
Sold on a plan
$160.23K 1,100 at 145.66
7.7%
Planned (10b5-1)
10 Jun 2026
Garrison Michael David EVP & Pres Med.Essntl&BioPharm
Sold on a plan
$166.63K 1,100 at 151.48
7.2%
Planned (10b5-1)
1 Jun 2026
Polen Thomas E Jr Chairman, CEO and President
Sold on a plan
$404.51K 2,764 at 146.35
2.4%
Planned (10b5-1)
26 May 2026
Feld Michael EVP, Chief Revenue Officer
Sold on a plan
$11.05K 75 at 147.35
0.4%
Planned (10b5-1)
27 Apr 2026
Feld Michael EVP, Chief Revenue Officer
Sold on a plan
$11.24K 74 at 151.94
0.3%
Planned (10b5-1)
26 Mar 2026
Feld Michael EVP, Chief Revenue Officer
Sold on a plan
$11.76K 75 at 156.83
0.4%
Planned (10b5-1)
26 Feb 2026
Feld Michael EVP, Chief Revenue Officer
Sold on a plan
$13.64K 75 at 181.84
0.4%
Planned (10b5-1)
18 Feb 2026
SCOTT BERTRAM L Director
Sold at will
$174.03K 953 at 182.61
2.5%
Not planned
26 Jan 2026
Feld Michael EVP, CRO & Pres. Life Sciences
Sold on a plan
$15.20K 75 at 202.73
0.5%
Planned (10b5-1)
15 Jan 2026
Garrison Michael David EVP & Pres Med.Essntl&BioPharm
Sold on a plan 2×
$334.01K 1,610 at 207.46
11.7%
Planned (10b5-1)
26 Dec 2025
Feld Michael EVP, CRO & Pres. Life Sciences
Sold on a plan
$14.51K 74 at 196.08
0.4%
Planned (10b5-1)
17 Dec 2025
Garrison Michael David EVP & Pres Med.Essntl&BioPharm
Sold on a plan
$123.30K 629 at 196.03
4.6%
Planned (10b5-1)
1 Dec 2025
Feld Michael EVP, CRO & Pres. Life Sciences
Sold on a plan
$14.50K 75 at 193.36
0.5%
Planned (10b5-1)
7 Nov 2025
SCOTT BERTRAM L Director
Sold at will
$38.32K 217 at 176.58
0.6%
Not planned
27 Oct 2025
Feld Michael EVP & President, Life Sciences
Sold on a plan
$10.60K 57 at 186.01
0.7%
Planned (10b5-1)
Showing 1–21 of 21.